Along with HSCT, immunoglobulin replacement therapy and antimicrobial prophylaxis are key treatment approaches for PGM3 deficiency patients (170, 174, 179). This evidence concerns the gene PGM3 and hyperinsulinemic hypoglycemia, familial, 4.